EagleBio’s Intact FGF-21 ELISA
was recently utilized in Boston study by Beth Israel Deaconess Medical Center,
Harvard Medical School. This assay is the first Intact FGF-21 ELISA
assay kit that truly measures the active human intact FGF-21 (1-181) with no
cross reaction to any FGF-21 fragments.
Shenoy, V. et. al. Elevated Serum
Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis. PLOS One. 2016. https://dx.doi.org/10.1371/journal.pone.0164351
Highlight from Publication:
“To assess the possibility that FGF21 is
released from the pancreas during acute injury in humans, we measured
circulating FGF21 in subjects with acute pancreatitis over the course of their
disease. We observed that acute pancreatitis subjects had significantly
increased peak circulating FGF21 values compared to healthy controls. Further,
peak FGF21 levels were observed four to six days after lipase levels peaked.
The timing of this elevation suggests that FGF21 may play a role in or be a
marker of disease recovery.” Read More